MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CAMP had $46,094K increase in cash & cash equivalents over the period. -$29,832K in free cash flow.

Cash Flow Overview

Change in Cash
$46,094K
Free Cash flow
-$29,832K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from issuance of common...
    • Change in fair value of derivati...
    • Deferred revenue
    • Others
Negative Cash Flow Breakdown
    • Operating lease assets and liabi...
    • Accounts payable
    • Prepaid expenses and other curre...
    • Others

Cash Flow
2025-12-31
Net loss
-80,403
Depreciation and amortization
1,639
Stock-based compensation expense
3,998
Change in fair value of derivative tranche liability
-29,830
Impairment of right-of-use asset
494
Loss on the sale of property and equipment
-258
Non-cash gain on lease modification
316
Non-cash lease expense
1,923
Non-cash interest expense
16
Prepaid expenses and other current assets
888
Accounts payable
-1,028
Accrued expenses and other liabilities
805
Operating lease assets and liabilities
2,996
Deferred revenue
17,115
Net cash used in operating activities
-29,553
Purchases of property and equipment
279
Proceeds from the sale of property and equipment
36
Net cash used in investing activities
-243
Proceeds from issuance of common stock, net of issuance costs of 3,966 and 5,747, respectively
57,516
Proceeds from issuance of pre-funded warrants, net of issuance costs 258
3,601
Proceeds allocated to the derivative tranche liability
14,930
Proceeds from exercise of common stock options
51
Principal payments on financing obligation
97
Principal payments on finance leases
111
Payments of deferred issuance costs
0
Net cash provided by financing activities
75,890
Net increase in cash, cash equivalents and restricted cash
46,094
Cash, cash equivalents and restricted cash at beginning of year
65,663
Cash, cash equivalents and restricted cash at end of period
111,757
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock, net of...$57,516K Proceeds allocated to thederivative tranche...$14,930K Proceeds from issuance ofpre-funded warrants, net of...$3,601K Proceeds from exercise ofcommon stock options$51K Net cash provided byfinancing activities$75,890K Canceled cashflow$208K Net increase incash, cash...$46,094K Canceled cashflow$29,796K Principal payments onfinance leases$111K Principal payments onfinancing obligation$97K Change in fair value ofderivative tranche...-$29,830K Deferred revenue$17,115K Stock-based compensationexpense$3,998K Non-cash lease expense$1,923K Depreciation andamortization$1,639K Accrued expenses andother liabilities$805K Impairment of right-of-useasset$494K Loss on the sale ofproperty and equipment-$258K Non-cash interestexpense$16K Proceeds from the sale ofproperty and equipment$36K Net cash used inoperating activities-$29,553K Net cash used ininvesting activities-$243K Canceled cashflow$56,078K Canceled cashflow$36K Net loss-$80,403K Purchases of property andequipment$279K Operating lease assets andliabilities$2,996K Accounts payable-$1,028K Prepaid expenses andother current assets$888K Non-cash gain on leasemodification$316K

Camp4 Therapeutics Corp (CAMP)

Camp4 Therapeutics Corp (CAMP)